Loading viewer...
investor_presentation
Format: PDF investor_presentation
ACETO Corporation announced the acquisition of generic drug-related assets from Citron Pharma and Lucid Pharma on November 3, 2016. The presentation outlines the transaction details, pro forma FY2017 outlook, and financing strategy. This strategic acquisition expands ACETO's portfolio in the generic pharmaceutical sector.
investor_presentation
23 Pages
Verisk Analytics, Inc.
investor_presentation
PAVmed
Greengage 2023 Q1 Investor Presentation
investor_presentationinvestor_presentation
21 Pages
Greengage Global Holding Ltd